Skip to content
Friday, November 6, 2026
Get expert reviews and insights on UK sports betting and on…

Patients Discontinuing Slimming Injections Regain Pounds Far More Rapidly Compared to Dieters

Image of medical syringe and weighing machine
Weight management involves long-term strategies.

Fresh analysis indicates that individuals who stop using new slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who end traditional diet and exercise regimens.

Research printed in a major medical journal demonstrates that while obese people frequently drop a large proportion of their body weight while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"People purchasing these treatments must be cognizant of the risk of fast weight regain when the treatment ends," warns lead investigator Dr. Susan Jebb.

That rate of recovery means a reversion to starting mass within about one and a half years.

Analyzing Approaches

The study, which reviewed 37 of studies involving thousands of patients, contrasted the outcomes of the injectable medications with conventional dieting.

The team emphasize that people who shed pounds through lifestyle changes alone typically see a less rapid weight regain—approximately 0.1 kg a month—post-intervention.

Understanding the Fast Rebound

Experts believe the mode of action of the jabs is key to understanding the amplified rebound.

These medications copy a body's own chemical called GLP-1, which controls appetite.

"Long-term administration of the hormone concentrations far above than the body's typical production might result in the system to produce less of its own natural GLP-1, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication means hunger is no longer kept in check, making excessive eating far more likely."

An Ongoing Condition?

Medical guidelines advise the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.

Professionals say that, given the high risk of relapse, the treatment is often long-term.

This perspective is reinforced by drug manufacturers, who note that the results "highlight the persistent nature of obesity," comparing it to managing conditions like diabetes.

Patient Accounts

Individuals who have stopped the jabs report a powerful resurgence of appetite.

"I experienced a trigger flipping and you become extremely hungry," described an individual.

The struggle is compounded if individuals have not developed sustainable dietary or behavioural modifications during therapy.

Widespread Interest

Figures show that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.

  • Use is higher among women compared to men.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion obtain the drugs through private healthcare rather than public health services.

Finally, clinicians stress that while GLP-1 drugs are effective tools for weight loss, they are not a magic solution and lasting health benefits hinges on integrated lifestyle changes.

AW
The writer

April White

A seasoned gambling analyst with over a decade of experience in UK betting markets, specializing in odds analysis and casino reviews.

Corex Bets UK

Type to search articles.